Contributor: Rosa Garcia-Verdugo

Rosa García-VerdugoRosa Garcia-Verdugo studied Biochemistry at University of Oviedo and, after working for a while in immunology at the Center for Biological Research (CIB) and another brief period of systems biology at the Center for Genomic Regulation (CRG), she eventually got her PhD in systems neurobiology at the Max-Planck-Institute of Neurobiology in Munich. Her research deals with neuronal plasticity in mouse visual cortex and big 2-photon microscopes.

Low poly brain illustration isolated on blue BG

Edvard Moser: ‘Neuroscience is evolving at an accelerated speed’

On 12 October, the Panel for the Future of Science and Technology (STOA), in collaboration with the International Brain Initiative (IBI) and the Kavli Foundation, organised a workshop at the European Parliament entitled "The International Brain Initiative – Shaping the future of globally coordinated neuroscience”. Keynote speaker was Prof Edvard Moser, founding director of the ...

Medical and healthcare nurses and doctors working to together fighting pandemic of corona virus disease, standing around with hands on top each other forming strong bond, motivation and coordination

A scientist’s opinion: Interview with Ira Haavisto about the EU Project HERoS

Interview with Ira Haavisto, Senior Research Manager at the Nordic Healthcare Group Finland, responsible for the public healthcare system analysis work package of the EU-funded Health Emergency Response in Interconnected Systems project. Why was intensive care unit occupancy an interesting research topic for the Health Emergency Response in Interconnected Systems project (HERoS)? We performed a ...

Medical and healthcare nurses and doctors working to together fighting pandemic of corona virus disease, standing around with hands on top each other forming strong bond, motivation and coordination

A scientist’s opinion: Interview with Gyöngyi Kovacs about the EU Project HERoS

Interview with Gyöngyi Kovacs, Erkko Professor in Humanitarian Logistics at the Hanken School of Economics (Finland) and coordinator of the EU-funded Health Emergency Response in Interconnected Systems project. What inspired the Health Emergency Response in Interconnected Systems (HERoS) project? HERoS kicked off around April 2020, just a few weeks after the first wave of the ...

Medical and healthcare nurses and doctors working to together fighting pandemic of corona virus disease, standing around with hands on top each other forming strong bond, motivation and coordination

HERoS: How can we improve our response to health emergencies?

A European research consortium was set up to learn from the present COVID-19 pandemic and to provide decision-makers with the necessary information and tools to more efficiently and effectively respond to future disease outbreaks. Some outcomes of this collaboration include a tool to optimise cross-border intensive care unit (ICU) occupancy in hospitals and a fact-checking observatory to combat misinformation.

Coronavirus Covid-19 treatment illustration banner

Tocilizumab : a treatment alternative in COVID-19 pneumonia

Patients with severe COVID-19 pneumonia often need to be mechanically intubated and have an increased mortality risk. Tocilizumab, a drug used against the cytokine storm underlying this clinical condition, has shown positive effects in clinical trials.

Coronavirus Covid-19 treatment illustration banner

A scientist’s opinion : Interview with Prof Cristina Mussini about covid-19 treatment

Interview with Professor Cristina Mussini, Head of the Department of Infectious Diseases and Tropical Medicine at the University of Modena and Reggio Emilia in Italy and member of the European AIDS Clinical Society. She has been actively involved in various recent studies on the clinical use of tocilizumab in patients with COVID-19 pneumonia. First a ...

Coronavirus Covid-19 treatment illustration banner

A scientist’s opinion : Interview with Dr Andrew Ip about covid-19 treatment

Interview with Dr Andrew Ip, a specialist in hematology/oncology at the John Theurer Cancer Center at Hackensack University Medical Center, USA, who has been involved in research on tocilizumab use in COVID-19 patients. Why did you choose tocilizumab to treat patients with COVID-19 pneumonia? Tocilizumab is a monoclonal antibody that inhibits the interleukin-6 (IL-6) receptor. ...

Coronavirus Covid-19 treatment illustration banner

A scientist’s opinion : Interview with Dr Juan Victor San-Martin Lopez about covid-19 treatment

Interview with Dr Juan Victor San-Martín López, a physician specialising in infectious diseases and a member of the task force coordinating responses to the leishmaniasis outbreak in 2011 and to COVID-19 at the Hospital Universitario de Fuenlabrada, Spain. He reports on his experience with tocilizumab use in COVID-19 patients. What is the so-called cytokine storm? ...